Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • eab
    Member
    • May 2011
    • 66

    Illumina Multiplexing Primer 2.0

    A collaborator has prepared a custom library for our sequencing by amplifying with the following primers.

    Multiplexing PCR Primer 1.0:
    AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT

    Multiplexing PCR Primer 2.0:
    GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT

    I told them the library was not yet ready to sequence because Multiplexing PCR Primer 2.0 does not have a flowcell sequence (which it definitely doesn't). Am I correct that the library is not yet ready to sequence?

    I recognize the primer's name as belonging to an older version of the Illumina-supplied oligo scheme, but am not sure of how the final library was created in that scheme.

    Can someone who used the older scheme let us know if I know what I'm talking about?

    Thank you!
  • kwaraska
    Senior Member
    • Nov 2008
    • 131

    #2
    In the older scheme there was a third indexed primer if I recall.

    Illumina has a primer document that includes even back that far. I would post it here, but they do not want us to post it and they take it down.

    You can ask Illumina for it directly-it is called the "Illumina Customer Sequence Letter" In it are all the sequences-old and new-along with their copyright information. I'm pretty sure that is why they won't post it here. You are agreeing to the copyright by receiving it from them.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      Yesterday, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:10 AM
    0 responses
    9 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    30 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    40 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Working...